Hutchison China MediTech Ltd. appointed Mok Shu Kam Tony to serve as an independent nonexecutive director.
Mok co-founded Hong Kong's Lung Cancer Research Group and is also a board member at Sanomics Ltd.
Hutchison China MediTech names board member
COVID-19 Pandemic Likely To Cause US Telemedicine Boom
Gauging Supply Chain Risk In Volatile Times
Cannabis: Hashing Out a Budding Industry
IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help
Hutchison China MediTech names board member
- Author Mark Louie Bonayon
- Theme Healthcare & Pharmaceuticals
- Author
- Mark Louie Bonayon
- Theme
- Healthcare & Pharmaceuticals